Cargando…
pH-Responsive Lipid Nanocapsules: A Promising Strategy for Improved Resistant Melanoma Cell Internalization
SIMPLE SUMMARY: Only 13 to 50% of patients with metastatic melanoma respond to new commercialized therapies. The reason why the same chemotherapeutic treatments yield different responses in patients can be attributed to the degree of multidrug resistance (MDR) developed by the host tumor cells. For...
Autores principales: | Pautu, Vincent, Lepeltier, Elise, Mellinger, Adélie, Riou, Jérémie, Debuigne, Antoine, Jérôme, Christine, Clere, Nicolas, Passirani, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122844/ https://www.ncbi.nlm.nih.gov/pubmed/33922267 http://dx.doi.org/10.3390/cancers13092028 |
Ejemplares similares
-
Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors
por: Idlas, Pierre, et al.
Publicado: (2021) -
Model Affitin and PEG modifications onto siRNA lipid nanocapsules: cell uptake and in vivo biodistribution improvements
por: Resnier, Pauline, et al.
Publicado: (2019) -
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules
por: Clavreul, Anne, et al.
Publicado: (2015) -
Thymoquinone-loaded lipid nanocapsules with promising anticancer activity for colorectal cancer
por: Selmi, Mouna, et al.
Publicado: (2023) -
Lipid nanocapsules formulation and cellular activities evaluation of a promising anticancer agent: EAPB0503
por: Chouchou, Adrien, et al.
Publicado: (2017)